{"id":"NCT00603798","sponsor":"Graceway Pharmaceuticals, LLC","briefTitle":"Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)","officialTitle":"A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of Six Weeks of Treatment With Imiquimod Creams for Actinic Keratoses","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2008-07","completion":"2008-07","firstPosted":"2008-01-29","resultsPosted":"2010-06-22","lastUpdate":"2010-06-29"},"enrollment":490,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratosis"],"interventions":[{"type":"DRUG","name":"Imiquimod cream","otherNames":[]},{"type":"DRUG","name":"Placebo cream","otherNames":[]},{"type":"DRUG","name":"Imiquimod cream","otherNames":[]}],"arms":[{"label":"3.75% imiquimod cream","type":"ACTIVE_COMPARATOR"},{"label":"2.5% imiquimod cream","type":"ACTIVE_COMPARATOR"},{"label":"Placebo cream","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether imiquimod creams are effective in treating Actinic Keratoses when applied to the face or balding scalp.\n\nActinic keratosis (AK) is a skin condition that shows up on skin routinely exposed to the sun, such as the face, scalp, shoulders, chest, back, arms, and hands. The active ingredient contained in the study cream for this study is the same as that of the approved product Aldara, which has shown to be safe and effective for the treatment of AKs.","primaryOutcome":{"measure":"Number of Participants With Complete Clearance of AK Lesions","timeFrame":"End of Study the Week 17 visit","effectByArm":[{"arm":"3.75% Imiquimod Cream","deltaMin":55,"sd":null},{"arm":"2.5% Imiquimod Cream","deltaMin":41,"sd":null},{"arm":"Placebo Cream","deltaMin":9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":26,"countries":["United States"]},"refs":{"pmids":["20133012"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":162},"commonTop":["Application site pruritus","Application site pain","Application site irritation"]}}